- Home
- RNXT vs FTHM Comparison
RNXT vs FTHM Comparison
Compare RNXT & FTHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RNXT | FTHM |
|---|---|---|
| Founded | 2012 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.4M | 28.8M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | RNXT | FTHM |
|---|---|---|
| Price | $1.81 | $0.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $8.25 | $2.50 |
| AVG Volume (30 Days) | ★ 1.4M | 82.7K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 20.00 | ★ 32.71 |
| EPS | ★ N/A | N/A |
| Revenue | $1,123,000.00 | ★ $420,477,000.00 |
| Revenue This Year | $194.66 | $11.67 |
| Revenue Next Year | $279.78 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2511.63 | 25.45 |
| 52 Week Low | $0.70 | $0.40 |
| 52 Week High | $2.59 | $3.37 |
Technical Indicators
Market Signals| Indicator | RNXT | FTHM |
|---|---|---|
| Relative Strength Index (RSI) | 52.90 | 31.40 |
| Support Level | $0.83 | $0.48 |
| Resistance Level | $2.59 | $0.71 |
| Average True Range (ATR) | 0.27 | 0.04 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 35.61 | 0.00 |
Price Performance
Historical ComparisonAbout RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, and Software as a Service (SaaS) offerings to brokerages and agents by leveraging intelliAgent , proprietary cloud-based software. The Company's three operating and reportable segments: Real Estate Brokerage, Mortgage, and Title. The majority of revenue is from Real Estate Brokerage, which provides real estate brokerage services.